Get started
Author

Agnieszka Końska

Observed names: A. Końska, Agnieszka Konska
ORCID: 0009-0009-4077-7555
Observed ORCID: 0009-0009-4077-7555
OpenAlex ID: A5018235016
Carfilzomib, lenalidomide, and dexamethasone or lenalidomide alone as maintenance therapy after autologous stem-cell transplantation in patients with multiple myeloma (ATLAS): interim analysis of a randomised, open-label, phase 3 trial
2023 · Dominik Dytfeld, Tomasz Wróbel, et al. · The Lancet Oncology · 85
PDF
Outcomes of treatment with dose‐adjusted EPOCH‐R or R‐CHOP in primary mediastinal large B‐cell lymphoma
2019 · Agata Malenda, Agnieszka Kołkowska‐Leśniak, et al. · European Journal Of Haematology · 41
Mass spectrometry–based assessment of M protein in peripheral blood during maintenance therapy in multiple myeloma
2024 · Tadeusz Kubicki, Dominik Dytfeld, et al. · Blood · 40
PDF
Early efficacy and safety of obinutuzumab with chemotherapy in previously untreated patients with follicular lymphoma: A real-world retrospective report of the Polish Lymphoma Research Group
2023 · Ewa Paszkiewicz-Kozik, Iwona Hus, et al. · Advances in Clinical and Experimental Medicine · 7
PDF
Carfilzomib, lenalidomide, and dexamethasone compared with lenalidomide treatment after autologous haematopoietic stem-cell transplantation in patients with multiple myeloma (ATLAS): primary analysis of a randomised, open-label, phase 3 trial
2026 · Dominik Dytfeld, Tomasz Wróbel, et al. · The Lancet Haematology · 6
Carfilzomib, lenalidomide, and dexamethasone (KRd) versus bortezomib, lenalidomide and dexamethasone (VRd) in patients with newly diagnosed multiple myeloma (NDMM) – interim results from the randomized Phase III COBRA trial.
2025 · Dominik Dytfeld, Tadeusz Kubicki, et al. · Blood · 5
PDF
Longitudinal Assessment of Minimal Residual Disease (MRD) in the ATLAS Randomized Phase 3 Trial of Post-Transplant Treatment with Carfilzomib, Lenalidomide, and Dexamethasone (KRd) Versus Lenalidomide (R) Alone in Patients with Newly Diagnosed Multiple Myeloma (NDMM)
2023 · Tadeusz Kubicki, Dominik Dytfeld, et al. · Blood · 5
Daratumumab or active observation for asymptomatic biochemical relapse in patients with multiple myeloma
2026 · Krzysztof Jamroziak, Dominik Dytfeld, et al. · British Journal of Haematology · 3
PDF
Health-related quality of life in patients with multiple myeloma treated in the phase 3 ATLAS trial of post-transplant maintenance with carfilzomib, lenalidomide, dexamethasone or lenalidomide alone
2024 · Tadeusz Kubicki, Krzysztof Jamroziak, et al. · Polskie Archiwum Medycyny Wewnętrznej · 3
Doksycyklina w terapii amyloidozy układowej z zajęciem serca
2018 · Justyna Łyczkowska-Piotrowska, Aleksander Salomon-Perzyński, et al. · Hematologia · 3
PDF
Safe administration of rituximab in patients with chronic lymphocytic leukemia and a history of obinutuzumab‑associated anaphylaxis
2018 · Aleksander Salomon‑Perzyński, Agnieszka Końska, et al. · Polskie Archiwum Medycyny Wewnętrznej · 3
PDF
Mass Spectrometry-Based Assessment of M-Protein in Peripheral Blood during Maintenance Therapy in Multiple Myeloma (MM) in the Phase III ATLAS Trial
2023 · Tadeusz Kubicki, Dominik Dytfeld, et al. · Blood · 2
Jak leczymy pacjenta z nowo rozpoznaną amyloidozą łańcuchów lekkich pośredniego ryzyka? Rola doksycykliny w terapii amyloidozy z zajęciem serca
2018 · Aleksander Salomon-Perzyński, Agnieszka Końska, et al. · Hematologia · 2
PDF
Daratumumab-based treatment of AL amyloidosis in Poland — a multi-center real-world-data study
2025 · Mateusz Ziarkiewicz, Magdalena Olszewska-Szopa, et al. · Acta Haematologica Polonica · 1
PDF
The Outcome of the First-Line Therapy of Patients with Follicular Lymphoma during COVID-19 Pandemic. a Real-World Data from the Polish Lymphoma Research Group (PLRG)
2023 · Ewa Paszkiewicz-Kozik, Monika Palka, et al. · Blood · 1
Coexistence of chronic lymphocytic leukemia and NK/T lymphoma of the nasopharynx in a patient treated with ibrutinib
2023 · Aleksandra Rogowska, Agnieszka Końska, et al. · Hematology in Clinical Practice · 1
PDF
Extramedullary plasmacytoma of the larynx manifesting as chronic hypertrophic laryngitis
2022 · Elżbieta Szczepanek, Anna Rzepakowska, et al. · Acta Haematologica Polonica · 1
S175: Atlas: a Phase 3 Randomized Trial of Carfilzomib, Lenalidomide, and Dexamethasone Versus Lenalidomide Alone After Stem-cell Transplant for Multiple Myeloma
2022 · D. Dytfeld, T. Wróbel, et al. · HemaSphere · 1
Powikłania autologicznego przeszczepienia krwiotwórczych komórek macierzystych u pacjentki z układową amyloidozą AL
2020 · Agnieszka Końska, Bartosz Puła, et al. · Hematologia · 1
Myeloid/lymphoid neoplasm with eosinophilia and FIP1L1::PDGFRA presenting as chronic myeloproliferative neoplasm in the myeloid blast phase: a case report and a review of the literature
2024 · Dorota Stankevič, Agnieszka Końska, et al. · Acta Haematologica Polonica
PDF
Health-Related Quality of Life in Polish Patients with Multiple Myeloma Treated in the Phase 3 ATLAS Trial of Post-Transplant Maintenance with Carfilzomib, Lenalidomide, Dexamethasone or Lenalidomide Alone
2023 · Tadeusz Kubicki, Ben A Derman, et al. · Blood
Rituximab and Chemotherapy for Newly Diagnosed Follicular Lymphoma: Real-World Report of Polish Lymphoma Research Group
2022 · Ewa Paszkiewicz-Kozik, Malgorzata Debowska, et al. · Chemotherapy
Safety and Early Efficacy of Obinutuzumab in Combination with Chemotherapy in Treatment Naive Patients with Follicular Lymphoma - Report of Polish Lymphoma Research Group (PLRG)
2021 · Ewa Paszkiewicz-Kozik, Iwona Hus, et al. · Blood
Substytucja immunoglobulin u chorych na przewlekłą białaczkę limfocytową i szpiczaka plazmocytowego
2015 · Krzysztof Jamroziak, Agnieszka Końska · Acta Haematologica Polonica
Works count: 24
Citation count: 211
H-index: 5
I10-index: 3
Year
Topic
Type